NewCardio, Inc. (NWCI)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jul 18, 2025
Bally's Revenue
NewCardio had revenue of $9.88K in the quarter ending September 30, 2011, a decrease of -90.04%. This brings the company's revenue in the last twelve months to $238.58K, up 40.90% year-over-year. In the year 2010, NewCardio had annual revenue of $257.40K.
Revenue (ttm)
238.58K
Revenue Growth
+40.90%
P/S Ratio
0.00
Revenue / Employee
23.86K
Employees
10
Market Cap
41.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2010 | 257.40K | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |